ChemAbout

ChemAbout is a B2B platform where chemical buyers and suppliers discover each other.

Post a purchase requestList your products (for suppliers)
© 2026 ChemAbout
Compound Index|Demand Board|Insights|Exhibitions|Compliance|Help Center|Privacy Policy|Terms of Service|[email protected]
Home/Compounds/Pharmaceutical Intermediate/Vedotin
C39H67N5O7
718 g/mol
Pharmaceutical IntermediateDanger

Conjugated form of mc-vc-PAB-MMAE

CAS646502-53-6
Category
Pharmaceutical Intermediate
Compound Class
Peptide
Primary Use
Pharmaceutical Intermediate

This compound is a conjugated form of the antimitotic agent monomethyl auristatin E (MMAE), linked through a maleimidocaproyl-valine-citrulline-p-aminobenzylcarbamate (mc-vc-PAB) spacer. It is primarily used as an intermediate in the manufacturing of antibody-drug conjugates (ADCs), enabling the stable attachment of the cytotoxic payload to targeting antibodies.

antibody-drug conjugate manufacturing intermediateresearch reagent for ADC development studies

Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.

Sourcing Conjugated form of mc-vc-PAB-MMAE?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→

Related Compounds

StrongStructure SimilarSimilarity 0.87

(2S)-2-[[(2S)-2-(dimethylamino)-3-methylbutanoyl]amino]-N-[(3R,4S,5S)-1-[(2S)-2-[(1R,2R)-3-[[(1S,2R)-1-hydroxy-1-phenylpropan-2-yl]amino]-1-methoxy-2-methyl-3-oxopropyl]pyrrolidin-1-yl]-3-methoxy-5-methyl-1-oxoheptan-4-yl]-N,3-dimethylbutanamide

CAS160800-57-7

pharmaceutical raw material

SimilarStructure SimilarSimilarity 0.78

Monomethyl auristatin F

CAS745017-94-1

pharmaceutical intermediate

ApplicationSame Use

VC-PAB-MMAE

CAS644981-35-1

pharmaceutical intermediate

ReferenceSame Category

N-(2-Bromo-4,5-difluorophenyl)acetamide

CAS64695-81-4

pharmaceutical intermediate

ReferenceSame Category

Gabapentin-lactam

CAS64744-50-9

pharmaceutical intermediate

ReferenceSame Category

1-Bromo-2-methoxyethane

CAS6482-24-2

pharmaceutical intermediate

ReferenceSame Category

L-Phenylglycinamide

CAS6485-52-5

pharmaceutical intermediate

Referencestereoisomer of

Monomethyl auristatin E

CAS474645-27-7

pharmaceutical intermediate

Related Reading

Therapeutic Peptides in 2026: This Year's Breakthroughs

2026 has been a concentrated year for peptide therapeutics. Efficacy reached a new high in late-stage trials, the obesity field moved beyond the incretins to amylin, the oral route reached weight management, and peptide-guided radioligand therapy kept advancing — each point tied to a specific 2025–2026 result.

Read more

Safety Reference

Toxic
Toxic
Harmful
Harmful
Danger
H300Fatal if swallowed
H310Fatal in contact with skin
H330Fatal if inhaled
H315Causes skin irritation
H319Causes serious eye irritation
H335May cause respiratory irritation
Identifiers
IUPAC Name

(2S)-N-[(2S)-1-[[(3R,5S)-1-[(2S)-2-[(1R,2R)-3-[[(1S,2R)-1-hydroxy-1-phenylpropan-2-yl]amino]-1-methoxy-2-methyl-3-oxopropyl]pyrrolidin-1-yl]-3-methoxy-5-methyl-1-oxoheptan-4-yl]-methylamino]-3-methyl-1-oxobutan-2-yl]-3-methyl-2-(methylamino)butanamide

InChIKey

DASWEROEPLKSEI-AWNAIHLBSA-N

SMILES

CC[C@H](C)C([C@@H](CC(=O)N1CCC[C@H]1[C@@H]([C@@H](C)C(=O)N[C@H](C)[C@H](C2=CC=CC=C2)O)OC)OC)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](C(C)C)NC

Synonyms (6)
  • PAB-MMAE
  • VcMMAE
  • Vedotin
  • Vedotin radical

Sourcing Conjugated form of mc-vc-PAB-MMAE?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→